Comprehensive Summary: Acute Decompensation & Acute-on-Chronic Liver Failure (ACLF)
Lecture by Prof. Sanjaya Satapathy | IDES Medical Education Series
1. Main Clinical Topics Discussed
- Natural history and progression of chronic liver disease to decompensated cirrhosis
- Definition, pathophysiology, and classification of Acute Decompensation (AD)
- Definition, grading, and prognostic framework of Acute-on-Chronic Liver Failure (ACLF)
- Distinction between ACLF and "sick cirrhosis"
- Role of MELD vs. ACLF in clinical decision-making
- Transplant urgency and ICU-level management principles
2. Key Learning Points, Guidelines, and Recommendations
Natural History of Chronic Liver Disease
- Silent chronic liver injury may persist 5–30 years before progressing to cirrhosis
- Compensated cirrhosis may remain stable for 3–15 years
- Decompensation marks a critical prognostic turning point; survival without transplantation is typically 1–5 years
- Decompensating events include: ascites, variceal bleeding, jaundice, hepatic encephalopathy (HE), and hepatocellular carcinoma
Acute Decompensation (AD)
- Defined as new onset or sudden worsening of major cirrhosis complications
- Can unmask previously undiagnosed cirrhosis
- 28-day mortality exceeds 15% (CANONIC study)
- Common triggers include:
- Infection (SBP, pneumonia, UTI, bacteremia) — most frequent
- Gastrointestinal/variceal bleeding
- Ongoing alcohol use
- Medication non-adherence (diuretics, lactulose)
- Acute kidney injury (AKI) from over-diuresis, dehydration, or hypotension
- No identifiable trigger in a substantial proportion of patients
Pathophysiology
- Driven by portal hypertension → bacterial translocation → systemic inflammation and oxidative stress
- Leads to splanchnic vasodilation, cardiac dysfunction, reduced effective circulating volume
- Activation of vasoconstrictors and sodium/water retention → ascites
- Circulatory failure + precipitating factors → extra-hepatic organ failures
ACLF Definition and Grading (CLIF-SOFA Score)
- ACLF = Acute Decompensation plus ≥1 extra-hepatic organ failure
- Organ systems assessed: liver, kidneys, brain, coagulation, circulation, lungs
- Organ failure defined at highest CLIF-SOFA severity categories:
- Kidney failure: markedly elevated creatinine or renal replacement therapy
- Brain failure: grade 3–4 HE
- Circulatory failure: vasopressor requirement
- Respiratory failure: severe hypoxemia
| ACLF Grade | Definition | 28-Day Mortality | 90-Day Mortality |
|---|
| Grade 1 | Isolated kidney failure OR single non-renal organ failure + mild renal dysfunction/low-grade HE | ~22% | ~40% |
| Grade 2 | Two organ failures | ~32% | >50% |
| Grade 3 | ≥3 organ failures | ~75–80% | ~80% |
3. Specific Clinical Data and Study Results Cited
- CANONIC Study: 28-day mortality in acute decompensation exceeds 15%
- Spectrum of acute decompensation outcomes (European data):
- ~20% meet ACLF criteria → 3-month mortality >50%
- ~20% have unstable decompensated cirrhosis (no ACLF) → 3-month mortality ~20%
- ~60% have stable decompensated cirrhosis → 1-year mortality <10%
- Precipitating factors in ACLF vs. AD without ACLF (European registry data):